Genesco price target raised to $25 from $23 at Truist

Truist raised the firm’s price target on Genesco (GCO) to $25 from $23 and keeps a Hold rating on the shares. The company reported “solid” Q1 results and reiterated its FY earnings per share guidance, despite now embedding the impacts of current tariffs as the Journeys’ turnaround continues to build momentum, the analyst tells investors in a research note. The firm noted gross margin headwinds through sourcing/efficiency initiatives and selective price increases in the second half, but visibility into how well consumers will be able to absorb these remains limited. While the firm remains impressed by Journeys’ turnaround progress, it is cautious on the choppy macro and potential demand fluctuations.